Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. (Q51656522)

9 April 2018

title

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. (English)

1 reference

9 April 2018

0 references

1 reference

7

Ravert HT

1 reference

9 April 2018

Robert F Dannals

8

object named as

Dannals RF

1 reference

9 April 2018

author name string

Frost JJ

1

1 reference

9 April 2018

Rosier AJ

2

1 reference

9 April 2018

Reich SG

3

1 reference

9 April 2018

Smith JS

4

1 reference

9 April 2018

Ehlers MD

5

1 reference

9 April 2018

Snyder SH

6

1 reference

9 April 2018

publication date

1 September 1993

1 reference

9 April 2018

published in

Annals of Neurology

1 reference

9 April 2018

volume

34

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

page(s)

423-431

1 reference

9 April 2018

Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome: clinical, biochemical, and neuropathologic studies of 2 new cases

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Dopamine deficiency in the cerebral cortex in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Use of PET methods for measurement of cerebral energy metabolism and hemodynamics in cerebrovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Multicompartmental analysis of [11C]-carfentanil binding to opiate receptors in humans measured by positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Models for in vivo kinetic interactions of dopamine D2-neuroreceptors and 3-(2'-[18F]fluoroethyl)spiperone examined with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410340331

21 January 2018

Identifiers

DOI

10.1002/ANA.410340331

1 reference

9 April 2018

1 reference

9 April 2018